Scientific Program
Wednesday, 1 August
08.00 – 15.30 — XII DERMOSCOPY COURSE OF HOSPITAL A. C. CAMARGO
Auditorium 1 – Hotel Caesar Business
- 08.00 – 08.20 Dermoscopy technique and devices: polarized X non-polarized – Susana Puig (Spain)
- 08.20 – 08.40 Dermoscopic criteria standardization: results of consensus meeting of IDS – Josep Malvehy (Spain)
- 08.40 – 09.00 Pattern Analysis Revisited: The Beauty and Beast Sign – Julia Casagrande (Brazil)
- 09.00 – 09.20 Dermoscopy lessons on nevogenesis – Giovanni Pellacani (Italy)
- 09.20 – 09.40 Spitz Nevus and Congenital Nevus - Francisco M. Paschoal (Brazil)
- 09.40 – 10.00 Vascular Structures by Dermoscopy - Susana Puig (Spain)
- 10.10 – 10.30 COFFEE BREAK
- 10.30 – 10.50 Dermoscopy of non-melanocytic skin tumors – Horacio Cabo (Argentina)
- 10.50 – 11.10 “Dying Nevus” X Regressing Melanoma - Giovanni Pellacani (Italy)
- 11.10 – 11.30 Recurrent Naevi X Recurrent Melanomas - Josep Malvehy (Spain)
- 11.30 – 11.50 Pigmented and Thin Nodular Melanomas – how to recognize – Susana Puig (Spain)
- 11.50 – 12.10 Dermoscopy usefulness to detection Facial Lentigo Maligna. - Gisele Gargantini Rezze (Brazil)
- 12.10 – 13.10 LUNCH
- 13.10 – 13.30 Melanonychia Striata – dermoscopy assessment. - Sergio Hirata (Brazil)
- 13.30 – 13.50 Dermoscopy patterns of acral benign and malignant lesions. - Juliana Machado (Brazil)
- 13.50 – 14.10 Dermoscopy of Pigmented Lesions of the Mucosa – Horacio Cabo (Argentina)
- 14.10 – 14.30 Multiple Nevi Patients and Digital Dermoscopy: Management Recommendation. – Bianca Costa Soares de Sá (Brazil)
- 14.30 – 15.30 Interactive Session – Susana Puig (Spain) / Josep Malvehy (Spain) / Giovanni Pellacani (Italy)
16.00 – 17.40 — SYMPOSIUM 1 — Skin Cancer Prevention: how are we doing?
Auditorium 1
- 16.00 – 16.10 Introduction – Perry Robins (USA)
- 16.10 – 16.25 Why is skin cancer incidence rising around the world? – Darrel Rigel (USA)
- 16.25 – 16.40 Photoprotection as practiced is effective in preventing skin cancer? – Fernando Stengel (Argentina)
- 16.40 – 16.55 Vitamin D, tanning, and skin cancer: what shall we tell our patients. – James Spencer (USA)
- 16.55 – 17.10 Ban artificial tanning is an effective measure? – Isabel Longo (Spain)
- 17.10 – 17.25 Skin Cancer: Brazilian National Programme. - Marcus Maia (Brazil)
- 17.25 – 17.40 EPIDERM: EU-project against skin cancer. – Eggert Stockfleth (Germany)
17.40 – 18.40 — SYMPOSIUM 2
Auditorium 1
- 17.40 – 18.10 Signaling pathway and skin cancer. – Brigitte Dréno (France)
- 18.10 – 18.40 CTLA-4 Antibody based treatment for skin cancer. – Caroline Robert (France)
18.40 – 19.10 — SATELLITE SYMPOSIUM – ISDIN
19.10 – Welcome Cocktail
Thursday, 2 August
08.00 – 09.50 — SYMPOSIUM 3 — Non melanoma Skin Cancer
Auditorium 1
- 08.00 – 08.15 The concept of field of cancerization. – Eggert Stockfleth (Germany)
- 08.17 – 08.32 Radiation therapy for skin cancer. – James Spencer (USA)
- 08.34 – 08.49 Targeted therapy for Basal Cell Carcinoma. – Rogerio Neves (USA)
- 08.51 – 09.06 Optical coherence tomography for the imaging of non-melanocytic cutaneous tumors. – Ana Maria Forsea (Romania)
- 09.08 – 09.28 Defining and management of High-Risk Cutaneous Squamous Cell Carcinoma. – Alvaro Acosta (Colombia)
- 09.30 – 09.45 Non melanoma skin cancer: precursor and progression. – Giovanni Pellacani (Italy)
08.00 – 09.50 — SYMPOSIUM 4 – Familial Melanoma and Dysplastic Nevus Syndrome
Auditorium 2
- 08.00 – 08.15 Clinical aspects of dysplastic nevus syndrome and familial melanoma. - Bianca Sá (Brazil)
- 08.15 – 08.30 Pathological aspects of melanocytic dysplasia. – Gilles Landman (Brazil)
- 08.30 – 08.45 Genetic assessment in familial melanoma. – Susana Puig (Spain)
- 08.45 – 09.00 Familial melanoma in Latin America. - Horacio Cabo (Argentina)
- 09.00 – 09.30 Discussion
10.00 – 10.30 — Coffee Break
10.30 – 11.00 — Special lecture 1
Auditorium 1
- 10.30 – 11.00 Targeted therapy for melanoma. - Caroline Robert (France)
11.00 – 12.20 — SYMPOSIUM 5 — Nonmelanoma Skin Cancer
Auditorium 1
- 11.00 – 11.20 Overview of vitamin D, health and current recommendations. - Henry Lim (USA)
- 11.20 – 11.35 New therapy for Squamous Cell Carcinoma. - Maritza Perez (USA)
- 11.35 – 11.50 Topical treatments of epithelial cancers: an update. – William Hanke (USA)
- 11.50 – 12.05 Dermoscopy of nonmelanoma skin cancer: what’s new? – Horacio Cabo (Argentina)
- 12.05 – 12.20 Delayed treatment of nonmelanoma skin cancer. – Leonard Goldberg (USA)
11.00 – 12.20 — CASES PRESENTATION 1
Auditorium 2
- Dermoscopy / Confocal / Histopathology
- Martin Mihm (USA)
- Gilles Landman (Brazil)
- Giovanni Pellacani (Italy)
- Miriam Nacagami (Brazil)
- Martin Sangueza (Bolivia)
- Alistar Cochan (USA)
- Francisco Paschoal (Brazil)
12.20 – 12.50 — OFFICIAL OPENING
Auditorium 1
13.00 – 13.50 — SATELLITE SYMPOSIUM – BIOLAB
13.00 – 13.50 — SATELLITE SYMPOSIUM – MERCK
12.50 – 14.00 — LUNCH/Poster
14.00 – 15.30 — SYMPOSIUM 6 — Rare tumors of the skin
Auditorium 1
- 14.00 – 14.13 Merkel cell carcinoma: new insights in prognostic markers (VEGF, cKIT, etc) – the role of pathology. – Jane Messina (USA)
- 14.15 – 14.28 Isolate limb perfusion (ILP) for Merkel cell carcinoma. - Andrea Cavalcanti (France)
- 14.30 – 14.43 Are cutaneous adnexal tumors markers of internal malignancy? – Mai P. Hoang (USA)
- 14.45 – 14.58 Cutaneous angiomatous lesions of interest for dermatologist. – Omar Sangueza (USA)
- 15.00 – 15.15 Diagnosis and treatment of B-cell lymphomas. – Robert Knobler (Austria)
- 15.17 – 15.30 Is there standardized surgical treatment of primary lesion of Merkel carcinoma which is universally accepted? – Francisco Belfort (Brazil)
14.00 – 15.30 — CASES PRESENTATION 2
Auditorium 2
- Dermoscopy / Confocal / Histopatology
- Martin Mihm (USA)
- Gilles Landman (Brazil)
- Giovanni Pellacani (Italy)
- Miriam Nacagami (Brazil)
- Adriano Piris (USA)
- Horacio Cabo (Argentina)
- Martin Sangueza (Bolivia)
- Alistar Cochan (USA)
- Josep Malvhey (Spain)
15.30 – 16.00 — Special Lecture 2
Auditorium 1
- Challenges, limitations and frontiers of melanoma immunotherapy. – Brigitte Dréno (France)
16.00 – 16.30 — Coffee Break
16.30 – 18.30 — SYMPOSIUM 7 — Cutaneous Lymphoma
Auditorium 1
- 16.30 – 16.45 Mycosis fungoides:is imunohistochemical evaluation always diagnostic? – Sergio Gonzales (Chile)
- 16.45 – 17.00 Update on the EORTC Treatment Platform for Treatment of CTCL – Robert Knobler (Austria)
- 17.00 – 17.15 Extranodal NK/T – cell lymphoma, nasal type. - José Antonio Sanches (Brazil)
- 17.15 – 17.30 Extracorporeal Photopheresis and CTCL. – Robert Knobler (Austria)
- 17.30 – 17.45 ATLL Are There Primary Cutaneous Forms? – Achilea Bittencourt (Brazil)
- 17.45 – 18.00 Hidroa vacciniforme like lymphoma. – Francisco Bravo (Peru)
- 18.00 – 18.15 Mycosis fungoides - Treatment of Advanced Stages. - Larissa Geskin (USA)
- 18.15 – 18.30 Discussion
16.30 – 18.40 — SYMPOSIUM 8 — Mohs Surgery
Auditorium 2
- 16.30 – 16.44 Technical Variations of Mohs Surgery. – Leonard Goldberg (USA)
- 16.46 – 17.00 Lesions on rare locations. – Abel Gonzales (Argentina)
- 17.02 – 17.16 Mohs Surgery of adnexial tumors. – Eugenio Pimentel (Brazil)
- 17.18 – 17.30 Mohs of Squamous Cell Carcinoma and Basal Cell Carcinoma. – Joseph Alcalay (Israel)
- 17.32 – 17.44 Mohs Surgery On Dermatofibrossarcoma Protuberans. – Alvaro Acosta (Colombia)
- 17.46 – 18.00 Controversies in Mohs Surgery.
- 18.02 – 18.16 Multidisciplinaire approach on difficult cases. - Selma Cernea (Brazil)
- 18.18 – 18.32 Mohs lab. How to improve time work. – Gaston Galimberti (Argentina)
Friday, 3 August
08.00 – 10.00 — SYMPOSIUM 9 — Skin Cancer: a multidisciplinary approach
Auditorium 1
- 08.00 – 08.20 Mohs surgery for melanoma in situ. – Joseph Alcalay (Israel)
- 08.20 – 08.35 Melanonyquia Striata. - Sergio Hirata (Brazil)
- 08.35 – 08.50 Sentinel lymph node biopsy: an update. – Alistar Cochan (USA)
- 08.50 – 09.05 Influence of the mitotic index in the treatment of cutaneous melanoma. – João Duprat (Brazil)
- 09.05 – 09.20 Surgery guided by confocal mycroscopy. – Josep Malvehy (Spain)
- 09.20 – 09.35 Electrochemotherapy with bleomycin. – John Thompson (Australia)
- 09.35 – 09.50 One Hundred thirty consecutive isolate limb perfusion (ILP) in melanoma patients with in-transit metastases. - Andrea Cavalcanti (France)
- 09.50 – 10.00 Discussion
08.00 – 10.00 — SYMPOSIUM 10 — Cutaneous Sarcomas and other Neoplasms
Auditorium 2
- 08.00 – 08.15 Molecular tools for diagnosing Dermatofibrossarcoma: new insigts regarding treatment with targed therapy. – Isabela Wernek (Brazil)
- 08.15 – 08.30 Dermatofibrosarcoma protuberans: analysis of different surgical techniques and use of Imatinib. - Rogerio Neves (USA)
- 08.30 – 08.45 Molecular Pathology in Cutaneous Sarcomas. – Alexander J. Lazar (USA)
- 08.45 – 09.00 Diagnosis and Treatment of Cutaneous Leiomyosarcoma. – Rogerio Neves (USA)
- 09.00 – 09.15 Angiossarcoma. – Omar Sangueza (USA)
- 09.15 – 09.30 Superficial Malignant Fibrous Histiocytoma. – Rogerio Neves (USA)
- 09.30 – 10.00 Discussion
10.00 – 10.30 — Coffee Break
10.30 – 11.00 — Special lecture 3
Auditorium 1
- Cutaneous lymphoma: new aspects. – Larissa Geskin (USA)
11.00 – 12.30 — SYMPOSIUM 11 — Skin Cancer in Immunocompromised
Auditorium 1
- 11.00 – 11.15 Skin cancer in organ transplant patients: epidemilogic and pathogenic aspects. - Claus Garbe (Germany)
- 11.17 – 11.32 How to prevent skin tumors in immunocompromised patients? – Isabel Longo (Spain)
- 11.34 – 11.49 Epidermodysplasia Verruciformis and skin cancer. - Walmar Roncalli Pereira de Oliveira (Brazil)
- 11.51 – 12.04 Management of epithelial cell carcinomas in transplant patients. – Eggert Stockfleeth (Germany)
- 12.06 – 12.21 Histopathological features of skin lesions in xeroderma pigmentosum. – Adriano Piris (USA)
11.00 – 12.30 — CASES PRESENTATION 3
Auditorium 2
- Dermoscopy / Confocal / Histopatology
- Susana Puig (Spain)
- Josep Malvhey (Spain)
- Rute Lellis (Brazil)
- Juan Maceira (Brazil)
- Omar Sangueza (USA)
12.30 – 13.15 — SATELLITE SYMPOSIUM – LEO PHARMA
12.30 – 14.00 — LUNCH / POSTER
14.00 – 15.30 — SYMPOSIUM 12 — Melanocytic Nevus
Auditorium 1
- 14.00 – 14.12 Nevogenesis: dermascopy and confocal microscopy insigths. – Giovanni Pellacani (Italy)
- 14.14 – 14.26 What is best practice management of the patient with multiple moles? - Claus Garbe (Germany)
- 14.28 – 14.40 Large congenital melanocytic nevi: clinical experience. - Flávia Bittencourt (Brazil)
- 14.42 – 14.54 Spitizoid lesion: pathology and management in the molecular era. – Martin Mihm (USA)
- 14.56 – 15.08 Follow up strategies for nevi: is it still of interest? – Jean-Jacques Grob (France)
- 15.10 – 15.22 Dermoscopy and confocal microscopy in atypical nevus. – Giovanni Pellacani (Italy)
14.00 – 15.30 — SYMPOSIUM 13 — Tumors of the nail apparatus
Auditorium 2
- 14:00 – 14:20 – Retrospective study of nail epidermoid carcinomas diagnosed in the department of dermatopathology of the St Pierre hospital over a 15 years period. - Bertrand Richert (Belgium)
- 14:20 – 14:40 – Surgical treatment of nail melanoma. - Eckart Haneke (Germany)
- 14:40 – 15:00 – Dermoscopy as a diagnostic tool for nail melanoma. – Nilton Di Chiacchio (Brazil)
- 15:00 – 15:20 – Management of unusual malignant nail tumors. - Walter Refkalefsky Loureiro (Brazil)
- 15:20 – 15:30 – Q&A
14.00 – 15.30 — FREE COMUNICATION
Auditorium 3
15.30 – 16.00 — Special Lecture 4
Auditorium 1
- Cutaneous side effects and new drugs: how to manage? Caroline Robert (France)
16.00 – 16.30 — Coffee Break
16.30 – 18.30 — SYMPOSIUM 14 — Melanoma
Auditorium 1
- 16.30 – 16.43 Prevention of melanoma with regular sunscreen use. – Darrel Rigel (USA)
- 16.45 – 16.58 Treatment of locally advanced melanoma. - Alberto Wainstein (Brazil)
- 17.00 – 17.13 Correlation between dermoscopic patterns, histological type and prognostic factors. - Francisco Paschoal (Brazil)
- 17.15 – 17.28 Melanomas detected in a follow-up program. – Susana Puig (Spain)
- 17.30 – 17.43 Lymphonodectomy indication for sentinel node positive. – John Thompson (Australia)
- 17.45 – 17.58 Evaluation of lymph node by ultrasound on Cutaneous Melanoma. - Miguel Brandão (Brazil)
- 18.00 – 18.13 Molecular and genetic techniques as adjuncts to histology: is it in daily practice? – Alistair Cochran (USA)
- 18.15 – 18.28 Melanocytic tumors of uncertain biological behavior (Epitheliod pigmented melanocytoma, Spitzoid tumors). – Adriano Piris (USA)
16.30 – 18.30 — FREE COMUNICATION
Auditorium 2
Saturday, 4 August
08.00 – 10.00 — SYMPOSIUM 15 — Cutaneous Melanoma
Auditorium 1
- 08.00 – 08.13 New insights in therapy of melanoma: the role of pathology. – Martin Mihm (USA)
- 08.15 – 08.28 Possibility of frozen in SLN biopsy. Pros and cons. – Ivan Abranches (Brazil)
- 08.30 – 08.43 Sentinel lymph node: prognosis or therapeutic? – John Thompsom (Australia)
- 08.45 – 08.58 Genetic counseling in melanoma patients. – Susana Puig (Spain)
- 09.00 – 09.13 Thin melanomas: analysis of microvessel density. - Helena O. da Costa (Brazil)
- 09.15 – 09.28 Anti angiogenic factors. – Hubert Pehamberger (Austria)
- 09.30 – 09.43 Surgery for problematic lentiginous melanoma (lentigo maligna and acral lentiginous melanoma). – Jean-Jacques Grob (France)
- 09.45 – 09.58 Epithelial tumors arising in patients submitted to targeted therapy for melanoma. – Jane Messina (USA)
08.30 – 10.00 — PATHOLOGY SYMPOSIUM 1
Auditorium 3
Coordinator – Gilles Landman (Brazil)
- 8.30 – 9.00The pathology of targeted therapy side effects. -Jane Messina (USA) & Mai Hoang (USA)
- 9.00 – 9.30The spectrum of Spitzoid lesions – what is the best approach for the patient and the physician? – Marthin Mihm (USA) & Jane Messina (USA)
- 9.30 – 10.00Is molecular pathology ready to substitute the histopathological classification of melanomas? – Alistair Cochran (USA) & Martin Mihm (USA)
10.00 – 10.30 — Coffee Break
10.30 – 11.00 — Special Lecture 5
Auditorium 1
- 10.30 – 11.00Imaging diagnoses of skin cancer: Current status and prospect futures. – Giovanni Pellacani (Italy)
11.00 – 13.00 — SYMPOSIUM 16 — Cutaneous Melanoma
Auditorium 1
- 11.00 – 11.15Acral melanoma: is it going to benefit from molecular pathology? – Gilles Landman (Brazil)
- 11.17 – 11.32Adjuvant therapy: lessons of the past. – Jean-Jacques Grob (France)
- 11.34 – 11.49Locoregional treatment of melanoma. – John Thompson (Australia)
- 11.51 – 12.06Optimum excision margins for melanoma. - John Thompson (Australia)
- 12.08 – 12.23The most impressive melanomas in Bolivia. – Martin Sangueza (Bolivia)
- 12.25 – 12.40Advanced imaging evaluation in a melanoma unit. – Josep Malvehy (Spain)
- 12.45 – 13.00Rare melanomas: desmoplastic, melanoma of soft parts. – Martin Mihm (USA)
11.00 – 13.00 — PATHOLOGY SYMPOSIUM 2
Auditorium 3
Coordinator - Gilles Landman (Brazil)
11.00 – 11.30 Are we obliged to search for mutations in the most common adnexal tumors associated with internal malignancy? - Mai Hoang (USA) & Alexander J. Lazar (USA)
11.30 – 12.00 Lentigo maligna – surgical margins and frozen section immunohistochemistry – yes or no? - Omar Sangueza (USA) & Juan Maceira (Brazil)
12.00 – 12.30 When should you trust molecular diagnosis in non-melanoma skin tumors? - Alexander J. Lazar (USA) & Sergio Gonzales (Chile)
12.30 – 13.00 Mycosis fungoides versus pseudolymphomatous T cell hyperplasia. Are the new drugs increasing pseudolymphomas? - Sergio Gonzales (Chile) & Omar Sangueza (USA)
